{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:57:12Z","timestamp":1790722632284,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Metab Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Childhood cancer survivors face an elevated risk of cardiometabolic disease that can emerge years after treatment completion. This Review summarises the mechanisms underlying this vulnerability, the contribution of biological, social, and lifestyle factors across the life course, and emerging opportunities for early prevention and interventions to improve long-term cardiometabolic health.<\/jats:p>","DOI":"10.1038\/s44324-026-00128-y","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:30:26Z","timestamp":1790674226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Childhood cancer and future cardiometabolic health"],"prefix":"10.1038","volume":"4","author":[{"given":"Abel","family":"Plaza-Florido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Carrera-Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomit","family":"Radom-Aizik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"P\u00e9rez-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lanfranconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Saco-Ledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Revuelta-Iniesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten K.","family":"Ness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"del Pozo Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Fiuza-Luces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"128_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. CA Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"128_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(13)70548-5","volume":"15","author":"G Gatta","year":"2014","unstructured":"Gatta, G. et al. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5\u2013a population-based study. Lancet Oncol. 15, 35\u201347 (2014).","journal-title":"Lancet Oncol."},{"key":"128_CR3","doi-asserted-by":"publisher","first-page":"e926","DOI":"10.1161\/CIR.0000000000001308","volume":"151","author":"TD Ryan","year":"2025","unstructured":"Ryan, T. D. et al. Cardiovascular toxicity in patients treated for childhood cancer: a scientific statement from the American Heart Association. Circulation 151, e926\u2013e943 (2025).","journal-title":"Circulation"},{"key":"128_CR4","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/S0140-6736(17)31610-0","volume":"390","author":"N Bhakta","year":"2017","unstructured":"Bhakta, N. et al. The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE). Lancet 390, 2569\u20132582 (2017).","journal-title":"Lancet"},{"key":"128_CR5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1001\/jamaoncol.2018.6634","volume":"5","author":"EAM Feijen","year":"2019","unstructured":"Feijen, E. A. M. et al. Derivation of anthracycline and anthraquinone equivalence ratios to doxorubicin for late-onset cardiotoxicity. JAMA Oncol. 5, 864\u2013871 (2019).","journal-title":"JAMA Oncol."},{"key":"128_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"G Minotti","year":"2004","unstructured":"Minotti, G., Menna, P., Salvatorelli, E., Cairo, G. & Gianni, L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56, 185\u2013229 (2004).","journal-title":"Pharmacol. Rev."},{"key":"128_CR7","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ng.3374","volume":"47","author":"F Aminkeng","year":"2015","unstructured":"Aminkeng, F. et al. A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer. Nat. Genet. 47, 1079\u20131084 (2015).","journal-title":"Nat. Genet."},{"key":"128_CR8","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.stem.2021.08.006","volume":"28","author":"T Magdy","year":"2021","unstructured":"Magdy, T. et al. RARG variant predictive of doxorubicin-induced cardiotoxicity identifies a cardioprotective therapy. Cell Stem Cell 28, 2076\u20132089.e7 (2021).","journal-title":"Cell Stem Cell"},{"key":"128_CR9","doi-asserted-by":"publisher","first-page":"117843","DOI":"10.1016\/j.lfs.2020.117843","volume":"255","author":"S L\u2019Abbate","year":"2020","unstructured":"L\u2019Abbate, S., Russo, I. & Kusmic, C. The role of metabolic diseases in cardiotoxicity associated with cancer therapy: What we know, what we would know. Life Sci. 255, 117843 (2020).","journal-title":"Life Sci."},{"key":"128_CR10","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","volume":"52","author":"Y Octavia","year":"2012","unstructured":"Octavia, Y. et al. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J. Mol. Cell Cardiol. 52, 1213\u20131225 (2012).","journal-title":"J. Mol. Cell Cardiol."},{"key":"128_CR11","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1200\/JCO.18.01764","volume":"37","author":"JE Bates","year":"2019","unstructured":"Bates, J. E. et al. Therapy-related cardiac risk in childhood cancer survivors: an analysis of the Childhood Cancer Survivor Study. J. Clin. Oncol. 37, 1090\u20131101 (2019).","journal-title":"J. Clin. Oncol."},{"key":"128_CR12","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1200\/JCO.2013.49.3205","volume":"31","author":"GT Armstrong","year":"2013","unstructured":"Armstrong, G. T. et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J. Clin. Oncol. 31, 3673\u20133680 (2013).","journal-title":"J. Clin. Oncol."},{"key":"128_CR13","doi-asserted-by":"crossref","unstructured":"Bates, J. E. et al. Cardiac substructure radiation dose and risk of late cardiac disease in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 41, 3826\u20133838 (2023).","DOI":"10.1200\/JCO.22.02320"},{"key":"128_CR14","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1200\/JCO.2012.46.6086","volume":"31","author":"CAJ Brouwer","year":"2013","unstructured":"Brouwer, C. A. J. et al. Endothelial damage in long-term survivors of childhood cancer. J. Clin. Oncol. 31, 3906\u20133913 (2013).","journal-title":"J. Clin. Oncol."},{"key":"128_CR15","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1093\/ejendo\/lvaf046","volume":"192","author":"SR van den Oever","year":"2025","unstructured":"van den Oever, S. R. et al. Metabolic syndrome in childhood, adolescent, and young adult cancer survivors: recommendations for surveillance from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Eur. J. Endocrinol. 192, S27\u2013S40 (2025).","journal-title":"Eur. J. Endocrinol."},{"key":"128_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35681","volume":"131","author":"M Bolier","year":"2025","unstructured":"Bolier, M. et al. Prevalence and determinants of metabolic syndrome in 2338 childhood cancer survivors: a Dutch Childhood Cancer Survivor LATER 2 study. Cancer 131, e35681 (2025).","journal-title":"Cancer"},{"key":"128_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000207607","volume":"15","author":"KH Darzy","year":"2009","unstructured":"Darzy, K. H. & Shalet, S. M. Hypopituitarism following radiotherapy revisited. Endocr. Dev. 15, 1\u201324 (2009).","journal-title":"Endocr. Dev."},{"key":"128_CR18","first-page":"243.e1","volume":"30","author":"TG Ketterl","year":"2024","unstructured":"Ketterl, T. G. et al. Impact of hematopoietic cell transplantation on cardiovascular risk factors and insulin sensitivity. Transpl. Cell Ther. 30, 243.e1\u2013243.e13 (2024).","journal-title":"Transpl. Cell Ther."},{"key":"128_CR19","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1182\/bloodadvances.2017010280","volume":"1","author":"HM Eissa","year":"2017","unstructured":"Eissa, H. M. et al. Chronic disease burden and frailty in survivors of childhood HSCT: a report from the St. Jude Lifetime Cohort Study. Blood Adv. 1, 2243\u20132246 (2017).","journal-title":"Blood Adv."},{"key":"128_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.bbmt.2016.08.019","volume":"23","author":"SH Armenian","year":"2017","unstructured":"Armenian, S. H. et al. National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: the Cardiovascular Disease and Associated Risk Factors Working Group Report. Biol. Blood Marrow Transpl. 23, 201\u2013210 (2017).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"128_CR21","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0140-6736(22)02471-0","volume":"401","author":"SB Dixon","year":"2023","unstructured":"Dixon, S. B. et al. Specific causes of excess late mortality and association with modifiable risk factors among survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet 401, 1447\u20131457 (2023).","journal-title":"Lancet"},{"key":"128_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1001\/jamaoncol.2025.0236","volume":"11","author":"JM Yeh","year":"2025","unstructured":"Yeh, J. M. et al. Accelerated aging in survivors of childhood cancer-early onset and excess risk of chronic conditions. JAMA Oncol. 11, 535\u2013543 (2025).","journal-title":"JAMA Oncol."},{"key":"128_CR23","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S1470-2045(24)00157-8","volume":"25","author":"RA Hammoud","year":"2024","unstructured":"Hammoud, R. A. et al. The burden of cardiovascular disease and risk for subsequent major adverse cardiovascular events in survivors of childhood cancer: a prospective, longitudinal analysis from the St Jude Lifetime Cohort Study. Lancet Oncol. 25, 811\u2013822 (2024).","journal-title":"Lancet Oncol."},{"key":"128_CR24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/eurjpc\/zwae317","volume":"33","author":"K Weinkauf","year":"2026","unstructured":"Weinkauf, K. et al. Cardiorespiratory fitness in childhood cancer survivors: a systematic review and meta-analysis. Eur. J. Prev. Cardiol. 33, 481\u2013489 (2026).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"128_CR25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jaccao.2024.08.005","volume":"6","author":"JD Groarke","year":"2024","unstructured":"Groarke, J. D. et al. Autonomic dysfunction among adult survivors of childhood cancer in the St. Jude Lifetime Cohort Study. JACC CardioOncol. 6, 775\u2013787 (2024).","journal-title":"JACC CardioOncol."},{"key":"128_CR26","doi-asserted-by":"crossref","unstructured":"Ehrhardt, M. J. et al. Improved cardiomyopathy risk prediction using global longitudinal strain and N-terminal-pro-B-type natriuretic peptide in survivors of childhood cancer exposed to cardiotoxic therapy. J. Clin. Oncol. 42, 1265\u20131277 (2024).","DOI":"10.1200\/JCO.23.01796"},{"key":"128_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jaccao.2024.10.004","volume":"7","author":"S Poudel","year":"2025","unstructured":"Poudel, S. et al. Serum proteins predict treatment-related cardiomyopathy among survivors of childhood cancer. JACC CardioOncol. 7, 56\u201367 (2025).","journal-title":"JACC CardioOncol."},{"key":"128_CR28","doi-asserted-by":"publisher","first-page":"e653","DOI":"10.1161\/CIR.0000000000000461","volume":"134","author":"R Ross","year":"2016","unstructured":"Ross, R. et al. Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a scientific statement from the American Heart Association. Circulation 134, e653\u2013e699 (2016).","journal-title":"Circulation"},{"key":"128_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.30746","volume":"71","author":"P Schmidt-Andersen","year":"2024","unstructured":"Schmidt-Andersen, P. et al. Physical capacity in children and adolescents with newly diagnosed cancer: a systematic review and meta-analysis. Pediatr. Blood Cancer 71, e30746 (2024).","journal-title":"Pediatr. Blood Cancer"},{"key":"128_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1200\/JCO.19.01661","volume":"38","author":"KK Ness","year":"2020","unstructured":"Ness, K. K. et al. Exercise intolerance, mortality, and organ system impairment in adult survivors of childhood cancer. J. Clin. Oncol. 38, 29\u201342 (2020).","journal-title":"J. Clin. Oncol."},{"key":"128_CR31","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1249\/MSS.0000000000003802","volume":"57","author":"MD Wogksch","year":"2025","unstructured":"Wogksch, M. D. et al. Associations between cardiopulmonary fitness and cardiovascular events in survivors of childhood cancer: a report from the St. Jude Lifetime Cohort. Med. Sci. Sports Exerc. 57, 2830\u20132837 (2025).","journal-title":"Med. Sci. Sports Exerc."},{"key":"128_CR32","doi-asserted-by":"publisher","first-page":"e2255395","DOI":"10.1001\/jamanetworkopen.2022.55395","volume":"6","author":"MJ Ehrhardt","year":"2023","unstructured":"Ehrhardt, M. J. et al. Association of modifiable health conditions and social determinants of health with late mortality in survivors of childhood cancer. JAMA Netw. Open 6, e2255395 (2023).","journal-title":"JAMA Netw. Open"},{"key":"128_CR33","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1158\/1055-9965.EPI-17-0510","volume":"26","author":"TM Gibson","year":"2017","unstructured":"Gibson, T. M. et al. Blood pressure status in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study. Cancer Epidemiol. Biomark. Prev. 26, 1705\u20131713 (2017).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"128_CR34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ejca.2022.05.038","volume":"172","author":"ECM Kooijmans","year":"2022","unstructured":"Kooijmans, E. C. M. et al. Hypertension in long-term childhood cancer survivors after treatment with potentially nephrotoxic therapy; DCCSS-LATER 2: renal study. Eur. J. Cancer 172, 287\u2013299 (2022).","journal-title":"Eur. J. Cancer"},{"key":"128_CR35","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1016\/j.clnu.2022.10.021","volume":"41","author":"A Brinksma","year":"2022","unstructured":"Brinksma, A. et al. Changes in body size and body composition in survivors of childhood cancer: seven years follow-up of a prospective cohort study. Clin. Nutr. 41, 2778\u20132785 (2022).","journal-title":"Clin. Nutr."},{"key":"128_CR36","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1158\/1055-9965.EPI-10-0163","volume":"19","author":"TL Miller","year":"2010","unstructured":"Miller, T. L. et al. Characteristics and determinants of adiposity in pediatric cancer survivors. Cancer Epidemiol. Biomark. Prev. 19, 2013\u20132022 (2010).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"128_CR37","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.3390\/cancers14102522","volume":"14","author":"E Latoch","year":"2022","unstructured":"Latoch, E. et al. Asymptomatic survivors of childhood acute lymphoblastic leukemia demonstrate a biological profile of inflamm-aging early in life. Cancers 14, 2522 (2022).","journal-title":"Cancers"},{"key":"128_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-09253-5","volume":"22","author":"H Ekedahl","year":"2022","unstructured":"Ekedahl, H. et al. Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors. BMC Cancer 22, 157 (2022).","journal-title":"BMC Cancer"},{"key":"128_CR39","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1002\/cncr.30857","volume":"123","author":"H Ariffin","year":"2017","unstructured":"Ariffin, H. et al. Young adult survivors of childhood acute lymphoblastic leukemia show evidence of chronic inflammation and cellular aging. Cancer 123, 4207\u20134214 (2017).","journal-title":"Cancer"},{"key":"128_CR40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1080\/08880018.2022.2049937","volume":"39","author":"SJ Rotz","year":"2022","unstructured":"Rotz, S. J. et al. Fecal microbiota of adolescent and young adult cancer survivors and metabolic syndrome: an exploratory study. Pediatr. Hematol. Oncol. 39, 629\u2013643 (2022).","journal-title":"Pediatr. Hematol. Oncol."},{"key":"128_CR41","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/08880018.2020.1759740","volume":"37","author":"R Thomas","year":"2020","unstructured":"Thomas, R. et al. Gut microbial composition difference between pediatric ALL survivors and siblings. Pediatr. Hematol. Oncol. 37, 475\u2013488 (2020).","journal-title":"Pediatr. Hematol. Oncol."},{"key":"128_CR42","doi-asserted-by":"publisher","first-page":"588","DOI":"10.4149\/neo_2023_230526N287","volume":"70","author":"V Bielik","year":"2023","unstructured":"Bielik, V. et al. The effect of physical exercise and dairy probiotics (Lactobacillus casei) on gut microbiome in childhood cancer survivors. Neoplasma 70, 588\u2013596 (2023).","journal-title":"Neoplasma"},{"key":"128_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/srep05654","volume":"4","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. Lactobacillus casei reduces susceptibility to type 2 diabetes via microbiota-mediated body chloride ion influx. Sci. Rep. 4, 5654 (2014).","journal-title":"Sci. Rep."},{"key":"128_CR44","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41591-019-0485-4","volume":"25","author":"J Scheiman","year":"2019","unstructured":"Scheiman, J. et al. Meta-omics analysis of elite athletes identifies a performance-enhancing microbe that functions via lactate metabolism. Nat. Med. 25, 1104\u20131109 (2019).","journal-title":"Nat. Med."},{"key":"128_CR45","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1089\/jayao.2017.0024","volume":"6","author":"AM Berkman","year":"2017","unstructured":"Berkman, A. M. et al. Racial differences in 20-year cardiovascular mortality risk among childhood and young adult cancer survivors. J. Adolesc. Young Adult Oncol. 6, 414\u2013421 (2017).","journal-title":"J. Adolesc. Young Adult Oncol."},{"key":"128_CR46","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11764-018-0678-8","volume":"12","author":"THM Keegan","year":"2018","unstructured":"Keegan, T. H. M. et al. Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study. J. Cancer Surviv. 12, 388\u2013397 (2018).","journal-title":"J. Cancer Surviv."},{"key":"128_CR47","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1200\/JCO.2015.66.3567","volume":"34","author":"Q Liu","year":"2016","unstructured":"Liu, Q. et al. Racial\/ethnic differences in adverse outcomes among childhood cancer survivors: the Childhood Cancer Survivor Study. J. Clin. Oncol. 34, 1634\u20131643 (2016).","journal-title":"J. Clin. Oncol."},{"key":"128_CR48","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1158\/0008-5472.CAN-20-2675","volume":"81","author":"Y Sapkota","year":"2021","unstructured":"Sapkota, Y. et al. Genetic variants associated with therapy-related cardiomyopathy among childhood cancer survivors of African ancestry. Cancer Res. 81, 2556\u20132565 (2021).","journal-title":"Cancer Res."},{"key":"128_CR49","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1200\/JCO.2015.63.4550","volume":"34","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. CELF4 variant and anthracycline-related cardiomyopathy: a Children\u2019s Oncology Group Genome-Wide Association Study. J. Clin. Oncol. 34, 863\u2013870 (2016).","journal-title":"J. Clin. Oncol."},{"key":"128_CR50","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/pbc.24505","volume":"60","author":"H Visscher","year":"2013","unstructured":"Visscher, H. et al. Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children. Pediatr. Blood Cancer 60, 1375\u20131381 (2013).","journal-title":"Pediatr. Blood Cancer"},{"key":"128_CR51","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jaccao.2025.06.001","volume":"7","author":"X Meng","year":"2025","unstructured":"Meng, X. et al. Epigenetic age acceleration mediates treatment effects on cardiometabolic and cardiovascular risk in childhood cancer survivors. JACC CardioOncol. 7, 691\u2013704 (2025).","journal-title":"JACC CardioOncol."},{"key":"128_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-68689-6","volume":"17","author":"T Eulalio","year":"2026","unstructured":"Eulalio, T. et al. Epigenome-wide analysis identifies DNA methylation mediators of treatment-related cardiometabolic risk in survivors of childhood cancer. Nat. Commun. 17, 1979 (2026).","journal-title":"Nat. Commun."},{"key":"128_CR53","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1200\/JCO.1997.15.4.1544","volume":"15","author":"JP Krischer","year":"1997","unstructured":"Krischer, J. P. et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J. Clin. Oncol. 15, 1544\u20131552 (1997).","journal-title":"J. Clin. Oncol."},{"key":"128_CR54","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1200\/JCO.2001.19.7.1926","volume":"19","author":"DM Green","year":"2001","unstructured":"Green, D. M. et al. Congestive heart failure after treatment for Wilms\u2019 tumor: a report from the National Wilms\u2019 Tumor Study group. J. Clin. Oncol. 19, 1926\u20131934 (2001).","journal-title":"J. Clin. Oncol."},{"key":"128_CR55","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1200\/JCO.2008.21.1425","volume":"27","author":"GT Armstrong","year":"2009","unstructured":"Armstrong, G. T. et al. Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J. Clin. Oncol. 27, 2328\u20132338 (2009).","journal-title":"J. Clin. Oncol."},{"key":"128_CR56","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s10741-019-09820-2","volume":"24","author":"C Cadeddu Dessalvi","year":"2019","unstructured":"Cadeddu Dessalvi, C. et al. Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens. Heart Fail. Rev. 24, 915\u2013925 (2019).","journal-title":"Heart Fail. Rev."},{"key":"128_CR57","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1161\/CIRCRESAHA.121.319901","volume":"130","author":"NS Wilcox","year":"2022","unstructured":"Wilcox, N. S. et al. Sex-specific cardiovascular risks of cancer and its therapies. Circ. Res. 130, 632\u2013651 (2022).","journal-title":"Circ. Res."},{"key":"128_CR58","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jaccao.2021.04.010","volume":"3","author":"R Rizwan","year":"2021","unstructured":"Rizwan, R. et al. Vo2peak in adult survivors of Hodgkin lymphoma: rate of decline, sex differences, and cardiovascular events. JACC CardioOncol. 3, 263\u2013273 (2021).","journal-title":"JACC CardioOncol."},{"key":"128_CR59","doi-asserted-by":"crossref","unstructured":"Caplin, D. A. et al. Effect of population socioeconomic and health system factors on medical care of childhood cancer survivors: a report from the Childhood Cancer Survivor Study. J. Adolesc. Young Adult Oncol. 6, 74\u201382 (2017).","DOI":"10.1089\/jayao.2016.0016"},{"key":"128_CR60","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jaccao.2023.01.011","volume":"5","author":"DH Noyd","year":"2023","unstructured":"Noyd, D. H. et al. Cardiovascular risk factor disparities in adult survivors of childhood cancer compared with the general population. JACC CardioOncol. 5, 489\u2013500 (2023).","journal-title":"JACC CardioOncol."},{"key":"128_CR61","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1158\/1055-9965.EPI-18-1384","volume":"28","author":"C Anderson","year":"2019","unstructured":"Anderson, C. et al. Disparities in mortality from noncancer causes among adolescents and young adults with cancer. Cancer Epidemiol. Biomark. Prev. 28, 1417\u20131426 (2019).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"128_CR62","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1136\/bjsports-2020-102955","volume":"54","author":"FC Bull","year":"2020","unstructured":"Bull, F. C. et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br. J. Sports Med. 54, 1451\u20131462 (2020).","journal-title":"Br. J. Sports Med."},{"key":"128_CR63","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1249\/MSS.0000000000001094","volume":"49","author":"C Fiuza-Luces","year":"2017","unstructured":"Fiuza-Luces, C. et al. Exercise intervention in pediatric patients with solid tumors: the Physical Activity in Pediatric Cancer Trial. Med. Sci. Sports Exerc. 49, 223\u2013230 (2017).","journal-title":"Med. Sci. Sports Exerc."},{"key":"128_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27216","volume":"65","author":"CR Howell","year":"2018","unstructured":"Howell, C. R. et al. Randomized web-based physical activity intervention in adolescent survivors of childhood cancer. Pediatr. Blood Cancer 65, e27216 (2018).","journal-title":"Pediatr. Blood Cancer"},{"key":"128_CR65","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jaccao.2025.11.002","volume":"8","author":"A Onerup","year":"2026","unstructured":"Onerup, A. et al. Potential of exercise for prevention of cardiovascular disease in survivors of childhood Hodgkin lymphoma. JACC CardioOncol. 8, 87\u201389 (2026).","journal-title":"JACC CardioOncol."},{"key":"128_CR66","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1055\/a-1073-8104","volume":"41","author":"JS Morales","year":"2020","unstructured":"Morales, J. S. et al. Exercise interventions and cardiovascular health in childhood cancer: a meta-analysis. Int. J. Sports Med. 41, 141\u2013153 (2020).","journal-title":"Int. J. Sports Med."},{"key":"128_CR67","first-page":"252","volume":"50","author":"R-C Ma","year":"2023","unstructured":"Ma, R.-C., Lu, H.-B., Li, J., Mao, Z.-X. & Xu, X.-X. Combined aerobic and resistance exercise interventions for children and adolescents with cancer: a systematic review and meta-analysis. Oncol. Nurs. Forum 50, 252\u2013262 (2023).","journal-title":"Oncol. Nurs. Forum"},{"key":"128_CR68","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1200\/JCO.2014.56.7511","volume":"32","author":"LW Jones","year":"2014","unstructured":"Jones, L. W. et al. Exercise and risk of major cardiovascular events in adult survivors of childhood Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. J. Clin. Oncol. 32, 3643\u20133650 (2014).","journal-title":"J. Clin. Oncol."},{"key":"128_CR69","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1001\/jamaoncol.2018.2254","volume":"4","author":"JM Scott","year":"2018","unstructured":"Scott, J. M. et al. Association of exercise with mortality in adult survivors of childhood cancer. JAMA Oncol. 4, 1352\u20131358 (2018).","journal-title":"JAMA Oncol."},{"key":"128_CR70","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/S0140-6736(18)31788-4","volume":"393","author":"W Willett","year":"2019","unstructured":"Willett, W. et al. Food in the Anthropocene: the EAT-Lancet Commission on healthy diets from sustainable food systems. Lancet 393, 447\u2013492 (2019).","journal-title":"Lancet"},{"key":"128_CR71","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/nutrit\/nuu062","volume":"73","author":"RR Iniesta","year":"2015","unstructured":"Iniesta, R. R., Paciarotti, I., Brougham, M. F. H., McKenzie, J. M. & Wilson, D. C. Effects of pediatric cancer and its treatment on nutritional status: a systematic review. Nutr. Rev. 73, 276\u2013295 (2015).","journal-title":"Nutr. Rev."},{"key":"128_CR72","doi-asserted-by":"publisher","first-page":"e28117","DOI":"10.1002\/pbc.28117","volume":"67","author":"RD Barr","year":"2020","unstructured":"Barr, R. D. & Stevens, M. C. G. The influence of nutrition on clinical outcomes in children with cancer. Pediatr. Blood Cancer 67, e28117 (2020).","journal-title":"Pediatr. Blood Cancer"},{"key":"128_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/jhn.13273","volume":"38","author":"AL Lovell","year":"2025","unstructured":"Lovell, A. L. et al. The evolution of nutritional care in children and young people with acute lymphoblastic leukaemia: a narrative review. J. Hum. Nutr. Diet. 38, e13273 (2025).","journal-title":"J. Hum. Nutr. Diet."},{"key":"128_CR74","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1177\/10434542211011050","volume":"38","author":"J Cohen","year":"2021","unstructured":"Cohen, J., Goddard, E., Brierley, M.-E., Bramley, L. & Beck, E. Poor diet quality in children with cancer during treatment. J. Pediatr. Oncol. Nurs. 38, 313\u2013321 (2021).","journal-title":"J. Pediatr. Oncol. Nurs."},{"key":"128_CR75","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3390\/nu16091315","volume":"16","author":"R Li","year":"2024","unstructured":"Li, R. et al. The role of diet in the cardiovascular health of childhood cancer survivors-a systematic review. Nutrients 16, 1315 (2024).","journal-title":"Nutrients"},{"key":"128_CR76","doi-asserted-by":"publisher","unstructured":"Mundle, R. et al. Longitudinal changes in childhood cancer survivor body mass index during early survivorship: associations with caregiver health-related parenting behaviors and survivor health behaviors. J. Cancer Surviv. https:\/\/doi.org\/10.1007\/s11764-026-02013-5 (2026).","DOI":"10.1007\/s11764-026-02013-5"},{"key":"128_CR77","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1158\/1055-9965.EPI-23-1601","volume":"33","author":"DN Friedman","year":"2024","unstructured":"Friedman, D. N. et al. Exercise and quality diet after leukemia: a randomized weight loss trial among adult survivors of childhood leukemia in the Childhood Cancer Survivor Study. Cancer Epidemiol. Biomark. Prev. 33, 1158\u20131166 (2024).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"128_CR78","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1161\/ATVBAHA.124.319863","volume":"45","author":"AAC Newman","year":"2025","unstructured":"Newman, A. A. C., Dalman, J. M. & Moore, K. J. Cardiovascular disease and cancer: a dangerous liaison. Arterioscler. Thromb. Vasc. Biol. 45, 359\u2013371 (2025).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"128_CR79","doi-asserted-by":"publisher","first-page":"729713","DOI":"10.3389\/fphys.2021.729713","volume":"12","author":"D Finke","year":"2021","unstructured":"Finke, D., Heckmann, M. B., Frey, N. & Lehmann, L. H. Cancer-a major cardiac comorbidity with implications on cardiovascular metabolism. Front. Physiol. 12, 729713 (2021).","journal-title":"Front. Physiol."}],"container-title":["npj Metabolic Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00128-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00128-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00128-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:01:16Z","timestamp":1790719276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44324-026-00128-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["128"],"URL":"https:\/\/doi.org\/10.1038\/s44324-026-00128-y","relation":{},"ISSN":["2948-2828"],"issn-type":[{"value":"2948-2828","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"40"}}